Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_assertion type Assertion NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_head.
- NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_assertion description "[However, grade II oligodendrogliomas with strong EGFR expression and 1p/19q codeletion showed reduced survival, compared with their codeleted counterparts with weaker EGFR expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_provenance.
- NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_assertion evidence source_evidence_literature NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_provenance.
- NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_assertion SIO_000772 21839716 NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_provenance.
- NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_assertion wasDerivedFrom befree-20140225 NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_provenance.
- NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_assertion wasGeneratedBy ECO_0000203 NP572132.RAcDzB4vTpRr1F3pYENQgweAL6d_tTGD-sXRbUqTeQJJI130_provenance.